Polycresol sulfonate vaginal suppository

Not yet clear.

The main ingredient of this product is polycresol sulfonaldehyde.

This product is a light yellow to light reddish brown suppository.

No data yet

Depending on the condition, a suppository can be placed in the vagina every other day or every day, and the course of treatment is determined by the doctor. If polycresol sulfonaldehyde concentrate is used to cauterize the lesion, a suppository should be placed every two cauterizations. For ease of use, the patient is best to lie on his back, soak the suppository with water, and then insert it deep into the vagina. It is usually appropriate to take the medication before going to bed at night, and use a sanitary belt to prevent contamination of clothing and bedding. If used during surgery, a vaginal plug should be used and removed 1-2 hours after surgery. See the diagram for how to open the vaginal suppository film or follow the doctor's advice.

Occasionally, there are local irritation symptoms (such as burning or pain) after use, which are usually tolerable and disappear quickly. Occasionally, there is a feeling of vaginal tightening and dryness. If any adverse events and/or adverse reactions occur during use of this product, please contact your doctor.

Patients who are allergic to any of the ingredients in Albotherapy are contraindicated to use it. During pregnancy, polycresol sulfonate can only be used when absolutely necessary, and the potential harm of the drug to mother and baby should be fully considered. Although animal tests have shown that this drug has no teratogenic effect, the results of human experiments have not yet been obtained, and it is not clear whether the active ingredients of this drug will be contained in the breast milk of lactating women.

Precautions for children: Forbidden. Precautions for pregnancy and lactation: Forbidden for pregnant and lactating women. During pregnancy, especially in the third trimester, any intracervical treatment should be avoided. Polycresol sulfonaldehyde is no exception. At this time, the potential harm of the drug to mother and baby should be fully considered. Although animal tests have shown that this drug has no teratogenic effect, the results of human trials have not yet been obtained. It is not clear whether the active ingredients of this drug will be contained in the breast milk of lactating women. Precautions for the elderly: It is not clear yet.

Polyphenol sulfonaldehyde can only be applied topically. Since interactions with other drugs cannot be ruled out, avoid using more than two drugs at the same time in the same area.

seal.

90mg

60 months